Samer Salamekh is an Oncology physician affiliated with Florida Cancer Specialists & Research Institute. OpenAlex indexes 16 publications with 885 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2 Shircliff Way
Jacksonville, FL 322044753
Telephone
904-388-2619Provider last certified this registry record 11 Dec 2024.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20254 payments
- Galvanize Therapeutics, IncProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
26.3%Gabapentinoids10.6%Gabapentin100%Part D≥16 patientsOpioid Agonist8.6%Oxycodone Hcl100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
18.7%Proton pump inhibitor12.6%Pantoprazole Sodium100%Part D≥18 patientsAluminum Complex6.1%Sucralfate100%Part D<11 patientsSensory organs
16.2%Corticosteroid16.2%Dexamethasone63%Betamethasone Dipropionate38%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Current State and Future Directions of Radiation Therapy for Pancreas Adenocarcinoma
Surgical Oncology Clinics of North America
2023 - SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial
International Journal of Radiation Oncology*Biology*Physics
2021 - Preoperative Radiation Therapy for Advanced Endometrial Cancer-Registry Analysis of Outcomes
International Journal of Radiation Oncology*Biology*Physics
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Bradley Monk, MD
Florida Cancer Specialists & Research Institute
Satish Shanbhag, MD, MPH
Florida Cancer Specialists & Research Institute
Ivor Percent, MD
Florida Cancer Specialists & Research Institute
Bradford Perez, MD
Florida Cancer Specialists & Research Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”